Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,077.55
+26.40 (2.51%)
At close: Jul 27, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.76 billion as of July 28, 2026. Its market cap has decreased by -18.54% in one year.
Market Cap
4.76B
Enterprise Value
4.25B
Revenue
1.69B
Ranking
n/a
PE Ratio
13.69
Stock Price
1,077.55
ChartMarket Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.76B, an increase of 14,306.38%. That is a compound annual growth rate of 22.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 4.76B | -1.12% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 7.93B |
| ZIM Laboratories | 6.43B |
| Kilitch Drugs (India) | 6.20B |
| Amanta Healthcare | 5.60B |
| Albert David | 3.95B |
| BDH Industries | 3.40B |
| Medico Remedies | 3.17B |
| Trident Lifeline | 3.13B |